These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3129746)
1. The relevance of pharmacological studies to sleep research in psychiatry. Janssen PA Pharmacopsychiatry; 1988 Jan; 21(1):33-7. PubMed ID: 3129746 [TBL] [Abstract][Full Text] [Related]
2. Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night? Janssen PA J R Soc Med; 1987 Jul; 80(7):409-13. PubMed ID: 3116237 [No Abstract] [Full Text] [Related]
3. [Development of new antipsychotic drugs]. Vanden Bussche G; Gelders YG; Heylen SL Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):13-25. PubMed ID: 2127339 [TBL] [Abstract][Full Text] [Related]
4. Study to establish the indication for the selective S2 antagonist ritanserin. Klieser E; Strauss WH Pharmacopsychiatry; 1988 Nov; 21(6):391-3. PubMed ID: 3149751 [TBL] [Abstract][Full Text] [Related]
5. [Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone]. Niemegeers CJ; Awouters F; Janssen PA Encephale; 1990; 16(2):147-51. PubMed ID: 1693560 [TBL] [Abstract][Full Text] [Related]
6. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Ceulemans DL; Hoppenbrouwers ML; Gelders YG; Reyntjens AJ Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107 [TBL] [Abstract][Full Text] [Related]
7. Ritanserin (R 55667) an original thymosthenic. Hoppenbrowers ML; Gelders Y; Vanden Bussche G Boll Chim Farm; 1986 Dec; 125(12):136S-147S. PubMed ID: 3109453 [No Abstract] [Full Text] [Related]
8. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200 [TBL] [Abstract][Full Text] [Related]
9. Ritanserin-induced changes in sleep-waking phases in rats. Kirov R; Moyanova S Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880 [TBL] [Abstract][Full Text] [Related]
10. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam. Bressa GM; Marini S; Gregori S Int J Clin Pharmacol Res; 1987; 7(2):111-9. PubMed ID: 3108171 [TBL] [Abstract][Full Text] [Related]
17. Serotonin antagonism in panic disorder: an open trial with ritanserin. Griez E; Pols H; Lousberg H Acta Psychiatr Belg; 1988; 88(5-6):372-7. PubMed ID: 3152708 [TBL] [Abstract][Full Text] [Related]